Cost, Financial Burden of Thyroid Cancer on Patients in US

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2022.0660?guestAccessKey=2da23cf6-d5a7-4b98-8ffb-d1d3b86a7342&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522

 

About The Study: Researchers examined the financial burden of thyroid cancer and propose a novel framework to guide future research and inform cancer care providers on cost considerations.

Authors: Benjamin James, M.D., M.S., of the Beth Israel Deaconess Medical Center in Boston, is the corresponding author.

 

(doi:10.1001/jamaoto.2021.0660)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.